Condition
Medullary Thyroid Cancer clinical trials and research
Research outlook What's coming for Thyroid cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Medullary Thyroid Cancer clinical trials that are recruiting, at sites in 3 countries (most in China (3), United States (1), Mexico (1)). By phase: Phase 4 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Medullary Thyroid Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Radiation plus tarlatamab for DLL3-expressing tumors | Phase 1/2 | Gilbert, Arizona and 2 other locations | Recruiting | Feb 7, 2025 |
| Understanding genetic causes of neuroendocrine tumors in Mexican patients | — | Mexico City, Mexico City and 2 other locations | Recruiting | Jul 26, 2024 |
| Guided surgery for medullary thyroid cancer using advanced imaging | — | Beijing | Recruiting | Feb 26, 2024 |
| Personalized mRNA vaccine for advanced endocrine tumors | — | Shanghai, Shanghai Municipality | Recruiting | Nov 21, 2023 |
| Evaluating Anlotinib for Advanced Medullary Thyroid Cancer | Phase 4 | Hefei, Anhui and 18 other locations | Recruiting | Apr 26, 2023 |
All recruiting trials (5)
-
Radiation plus tarlatamab for DLL3-expressing tumors
This trial will test whether giving tarlatamab together with standard palliative or consolidative radiation is safe for adults with DLL3-expressing or DLL3-prevalent tumors such as melanoma, medullary thyroid cancer, sinonasal undifferentiated carcinoma, esthesioneuroblastoma, and bladder cancer.
-
Understanding genetic causes of neuroendocrine tumors in Mexican patients
This study is trying to find out the genetic changes that cause neuroendocrine tumors in Mexican patients to help develop better treatments.
-
Guided surgery for medullary thyroid cancer using advanced imaging
This study is testing a new imaging technique to see if it can help doctors perform better surgeries for patients with medullary thyroid cancer.
-
Personalized mRNA vaccine for advanced endocrine tumors
This study is testing a personalized mRNA vaccine to see if it can help patients with advanced endocrine tumors who haven't had success with standard treatments.
-
Evaluating Anlotinib for Advanced Medullary Thyroid Cancer
This study is testing whether Anlotinib can help people with advanced medullary thyroid cancer feel better and manage their disease more effectively.
Related topics
Quick answers
How many Medullary Thyroid Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), United States (1 trial), Mexico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.